Eric Kleerup is a Respiratory physician affiliated with University of California, Los Angeles. OpenAlex indexes 156 publications with 9,875 citations (h-index 47); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90095
Telephone
310-825-6301Registry record last updated 28 Jun 2010.
Clinical trials
- Non-invasive Measures of Effects of Xolair in Asthma
Sponsor: University of California, Los Angeles
- Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Sponsor: University of California, Los Angeles
- Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
72.3%Corticosteroid39.9%Fluticasone Propionate23%Trelegy Ellipta17%Dulera14%Breo Ellipta13%Symbicort8%Qvar Redihaler7%Asmanex Hfa5%Breyna4%Fluticasone Propionate Hfa4%Arnuity Ellipta3%Breztri Aerosphere3%Part D<11 patientsbeta2-Adrenergic Agonist19.5%Albuterol Sulfate Hfa78%Ventolin Hfa18%Serevent Diskus5%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
16.2%Proton pump inhibitor8.6%Omeprazole56%Esomeprazole Magnesium44%Part D≥23 patientsCorticosteroid5.2%Prednisone100%Part D≥33 patients+ 1 more class in this area
Anti-infectives
6.2%Macrolide Antimicrobial3.5%Azithromycin100%Part D≥20 patientsFluoroquinolone Antibacterial1.6%Levofloxacin100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2011–2016 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Effects of Rare <i>SERPINA1</i> Variants on Lung Function and Emphysema in SPIROMICS
American Journal of Respiratory and Critical Care Medicine
2019 - Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals
Annals of the American Thoracic Society
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”